FEN1 Human

Flap Structure-Specific Endonuclease 1 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to FEN1

Flap endonuclease 1 (FEN1) is a structure-specific nuclease encoded by the FEN1 gene in humans. It plays critical roles in DNA replication and repair, including processing Okazaki fragments during lagging-strand synthesis and resolving 5' overhanging flaps in DNA repair pathways . FEN1 belongs to the XPG/RAD2 endonuclease family and is essential for maintaining genomic stability .

Enzymatic Activities

FEN1 exhibits three primary activities:

  1. 5' Flap Endonuclease: Cleaves 5' single-stranded DNA (ssDNA) flaps generated during Okazaki fragment maturation or long-patch base excision repair (BER) .

  2. 5'–3' Exonuclease: Processes nicked or gapped double-stranded DNA (dsDNA) .

  3. RNase H Activity: Degrades RNA in RNA-DNA hybrids .

DNA Replication and Repair

  • Okazaki Fragment Processing: Removes RNA primers and 5' flaps during lagging-strand synthesis .

  • Base Excision Repair (BER): Cleaves apurinic/apyrimidinic (AP) site-terminated flaps in long-patch BER .

  • Genome Stability: Prevents trinucleotide repeat expansions by resolving secondary DNA structures .

Interactions with Key Proteins

FEN1 collaborates with multiple proteins to execute its functions:

Interacting PartnerRole
PCNAEnhances FEN1’s endonuclease activity and recruits it to replication forks .
APEX1Coordinates with FEN1 during BER to transfer substrates .
WRN/BLMHelicases that resolve secondary structures to facilitate FEN1 cleavage .
EP300Acetylates FEN1, modulating its activity .

Cancer

  • Oncogenic Role: Overexpression correlates with tumor aggressiveness in multiple cancers .

  • Therapeutic Target: Synthetic lethality observed in BRCA1/2-deficient cancers. FEN1 inhibitors (e.g., C8) reduce viability in homologous recombination (HR)-defective cell lines and xenografts .

Cancer TypeResponse to FEN1 Inhibition
BRCA1/2-mutant cellsSelective killing due to inability to repair DNA double-strand breaks .
Colorectal (HCT116)Sensitivity linked to replication stress and defective DNA repair .

Viral Infections

  • HCMV Replication: Human cytomegalovirus (HCMV) immediate early protein 1 (IE1) stabilizes FEN1 and enhances its phosphorylation, promoting viral DNA synthesis .

Genetic and Biochemical Insights

  • Conserved Residues: Mutations in residues like R47 and R70 disrupt flap cleavage, underscoring their role in catalysis .

  • Yeast Homolog (Rad27): Deletion causes temperature sensitivity, genomic instability, and hypersensitivity to DNA-damaging agents .

Future Directions

  • Mechanistic Studies: Elucidate how FEN1 navigates complex DNA substrates in replication forks.

  • Drug Development: Optimize FEN1 inhibitors for clinical use in HR-deficient cancers .

Product Specs

Introduction
FEN1, a crucial enzyme in DNA replication and repair, plays a vital role in removing 5' overhanging flaps during DNA repair processes and Okazaki fragment processing in lagging strand DNA synthesis. Its interaction with AP endonuclease 1 during long-patch base excision repair facilitates coordinated protein loading onto the substrate, enabling efficient substrate transfer between the enzymes. As a member of the XPG/RAD2 endonuclease family, FEN1 is one of ten essential proteins required for cell-free DNA replication. Notably, DNA secondary structures can hinder FEN1's flap processing activity at specific trinucleotide repeats. This inhibition stems from the concealment of the 5' flap end, essential for FEN1 binding and cleavage. Consequently, such secondary structures can compromise FEN1's protective function, potentially leading to site-specific trinucleotide expansions.
Description
Recombinant Human FEN1, expressed in E. coli, is a purified, non-glycosylated polypeptide chain consisting of 380 amino acids (1-380 a.a.). With a molecular weight of 42.5 kDa, this protein is purified using standardized chromatography techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
This protein solution is supplied in a buffer containing 20mM Tris-HCl at pH 8.0, 1mM DTT, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep the vial refrigerated at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein like 0.1% HSA or BSA is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
SDS-PAGE analysis indicates a purity greater than 90.0%.
Synonyms
FEN-1, MF1, RAD2, Maturation Factor-1, MF-1, Flap endonuclease 1, Flap structure-specific endonuclease 1, Maturation factor 1, hFEN-1, DNase IV, FEN1.
Source
Escherichia Coli.
Amino Acid Sequence
MGIQGLAKLI ADVAPSAIRE NDIKSYFGRK VAIDASMSIY QFLIAVRQGG DVLQNEEGET TSHLMGMFYR TIRMMENGIK PVYVFDGKPP QLKSGELAKR SERRAEAEKQ LQQAQAAGAE QEVEKFTKRL VKVTKQHNDE CKHLLSLMGI PYLDAPSEAE ASCAALVKAG KVYAAATEDM DCLTFGSPVL MRHLTASEAK KLPIQEFHLS RILQELGLNQ EQFVDLCILL GSDYCESIRG IGPKRAVDLI QKHKSIEEIV RRLDPNKYPV PENWLHKEAH QLFLEPEVLD PESVELKWSE PNEEELIKFM CGEKQFSEER IRSGVKRLSK SRQGSTQGRL DDFFKVTGSL SSAKRKEPEP KGSTKKKAKT GAAGKFKRGK.

Q&A

What is the structural basis for FEN1's substrate specificity?

FEN1 exhibits remarkable substrate specificity through a sophisticated structural arrangement. Crystallographic analyses reveal FEN1 recognizes nicked double-stranded DNA that is bent approximately 100° with unpaired 3'- and 5'-flaps . The protein architecture includes:

  • A helical cap positioned above the active site

  • A gateway formed by two helices that enforces ssDNA threading

  • A two-metal-ion active site for catalysis

  • Structural elements that induce double-base unpairing flanking the scissile phosphate

This arrangement ensures precise positioning of the substrate, allowing FEN1 to cleave exactly at the junction between the single-stranded flap and double-stranded DNA, creating products that can be directly ligated . The structure-specific recognition occurs in a sequence-independent manner, enabling FEN1 to process diverse substrates throughout the genome.

How do the multiple catalytic activities of FEN1 relate to its diverse cellular functions?

FEN1 possesses multiple distinct nucleolytic activities that enable its participation in various DNA metabolic pathways:

ActivitySubstrateBiological Role
5'-flap endonuclease5'-flap structuresOkazaki fragment processing during replication
Gap endonucleaseGapped DNA structuresGeneration of DSBs for replication fork restart
5' exonucleaseNicked DNAProcessing of certain repair intermediates

These diverse activities allow FEN1 to function in multiple contexts including DNA replication, base excision repair, and potentially homologous recombination . The regulation of these different activities appears to involve protein-protein interactions, post-translational modifications, and substrate availability. During viral infections such as HCMV, viral proteins can selectively stimulate FEN1's gap endonuclease activity to facilitate viral DNA replication .

What is the current understanding of the threading versus tracking debate in FEN1 mechanism?

The mechanism by which FEN1 processes 5'-flaps has been debated between two models:

Threading model: The 5'-flap passes through a helical arch structure in the protein before cleavage occurs at the base of the flap.

Tracking/clamping model: FEN1 binds the flap without threading and tracks along it to the junction where cleavage occurs.

Recent crystallographic analyses strongly support the threading mechanism. The helical cap positioned above the gateway formed by two helices enforces ssDNA threading and creates specificity for free 5'-ends . This threading mechanism explains apparently contradictory biochemical data where bulky modifications at the 5'-end sometimes inhibit cleavage (consistent with threading) but are occasionally tolerated (suggesting flexibility in the threading process) .

The structural evidence demonstrates that FEN1 enforces substrate specificity through a threading mechanism that positions the scissile phosphate precisely at the active site, ensuring accurate incision of the 5'-flap.

What are the most effective methods for assessing FEN1 activity in vitro?

Researchers studying FEN1 employ several complementary approaches to assess its activity:

MethodApplicationAdvantages
Nuclease assays with synthetic substratesQuantitative measurement of cleavage activityAllows precise control of substrate structure and sequence
X-ray crystallographyStructural determination of FEN1-DNA complexesReveals atomic-level details of substrate recognition and catalysis
Single-molecule fluorescenceReal-time observation of FEN1-substrate interactionsCaptures transient intermediates and heterogeneity
Site-directed mutagenesisStructure-function analysisTests importance of specific residues (e.g., D181A mutation severely impairs activity)

For in vitro nuclease assays, optimal conditions typically include:

  • Divalent metal ions (Mg²⁺ or Mn²⁺) as essential cofactors

  • Physiological pH (7.5-8.0)

  • Salt concentrations mimicking cellular conditions

  • Carefully designed substrates with fluorescent or radioactive labels

When interpreting results, researchers should consider that in vitro conditions may not fully recapitulate the complexity of cellular environments where FEN1 operates within multiprotein complexes.

How can researchers effectively study FEN1 function in cellular contexts?

Cellular studies of FEN1 require approaches that address its essential nature and integration with other replication and repair proteins:

  • Genetic complementation assays: Human FEN1 functionally complements the yeast rad27 null mutant, providing a powerful system to evaluate FEN1 variants. This approach has demonstrated that human FEN1 rescues mutagen sensitivity, genetic instability, and synthetic lethal interactions in rad27-deficient yeast .

  • Conditional expression/depletion systems: Since complete FEN1 knockout is lethal, inducible systems allow controlled manipulation of FEN1 levels.

  • Dominant-negative approaches: Expression of catalytically inactive FEN1 (e.g., D181A) can disrupt endogenous FEN1 function. Mutant forms lacking nuclease activity exhibit dominant-negative effects on cell growth and genome stability similar to those seen with homologous yeast rad27 mutations .

  • Protein-protein interaction studies: Techniques like co-immunoprecipitation and proximity ligation assays reveal FEN1's interactions with replication machinery components.

  • Single-molecule and single-cell microscopy: These approaches track FEN1 dynamics in living cells, providing insights into its recruitment to replication and repair sites .

When designing cellular experiments, researchers should consider that FEN1 perturbations may have pleiotropic effects due to its involvement in multiple DNA metabolic pathways.

What viral systems provide insights into FEN1 regulation and function?

Viral systems offer unique windows into FEN1 regulation and function. Human cytomegalovirus (HCMV) provides a particularly informative model:

  • HCMV infection and FEN1 manipulation: The HCMV immediate early protein 1 (IE1) directly binds FEN1, enhancing its protein stability and promoting phosphorylation at serine 187 .

  • Functional consequences: IE1 binding correlates with nucleolar exclusion of FEN1, which stimulates its gap endonuclease activity .

  • Impact on viral replication: FEN1 depletion or inhibition during HCMV infection significantly reduces nascent viral DNA synthesis, demonstrating its importance for efficient viral replication .

  • Mechanistic insights: Studies suggest FEN1 is required for double-strand break formation during HCMV infection, potentially helping to restart stalled replication forks at difficult-to-replicate sites in viral genomes .

This viral system reveals a novel mechanism of FEN1 regulation through direct protein-protein interaction and provides evidence that FEN1's gap endonuclease activity can be selectively activated to overcome replication barriers—insights potentially relevant to understanding FEN1's roles in challenging genomic contexts.

How does FEN1 process Okazaki fragments during DNA replication?

FEN1 plays a critical role in Okazaki fragment maturation during lagging strand DNA synthesis:

  • RNA primers (~10 nucleotides) initiate Okazaki fragment synthesis on the lagging strand.

  • DNA polymerase δ extends these primers and can displace the 5'-end of the downstream Okazaki fragment, creating a 5'-flap structure.

  • FEN1 recognizes this structure and cleaves precisely at the flap base.

  • The resulting nick can be sealed by DNA ligase I to create a continuous DNA strand.

FEN1 must process approximately 50 million Okazaki fragments during each human cell cycle with extraordinary precision . Failure to accurately process these fragments would create gaps or overlaps that prevent efficient ligation, delay cell division, and potentially lead to genomic instability .

The efficiency of this process is enhanced through coordination with PCNA, which acts as a sliding clamp that recruits and positions FEN1 at the replication fork. The C-terminal region of FEN1 contains a PCNA-binding motif essential for this interaction .

How does FEN1 coordinate with other replication proteins?

FEN1 functions within an intricate network of protein interactions at the replication fork:

ProteinInteraction with FEN1Functional Significance
PCNADirect binding via C-terminal motifEnhances FEN1 activity; coordinates handoff between polymerase, FEN1, and ligase
DNA polymerase δFunctional coordinationCreates the 5'-flap substrate; synthetic lethality between FEN1/RAD27 and pol3 mutations
DNA ligase ISequential actionSeals the nick after FEN1 processing; also interacts with PCNA
RPABinding to long flapsDetermines processing pathway (short vs. long flap)
Dna2Sequential actionProcesses long RPA-coated flaps before FEN1 action

These interactions ensure efficient and coordinated Okazaki fragment maturation. The importance of these relationships is demonstrated by synthetic lethal interactions observed between FEN1/RAD27 and mutations in genes encoding these interacting partners, particularly DNA polymerase δ (POL3) and homologous recombination proteins (RAD51) .

What happens when FEN1 function is compromised during DNA replication?

Compromised FEN1 function during DNA replication has profound consequences:

  • Accumulation of unprocessed Okazaki fragments: Leading to persistent single-strand breaks and replication fork collapse.

  • Genomic instability: Functional analysis using the yeast system shows that FEN1 deficiency results in increased mutation rates, particularly expansions and contractions at repetitive sequences .

  • Increased recombination: Persistent flap structures can be processed by recombination pathways, leading to chromosomal rearrangements.

  • Cell cycle arrest: Accumulation of DNA damage activates checkpoints, causing cell cycle delays.

  • Synthetic lethality: FEN1/RAD27 deficiency becomes lethal when combined with defects in alternative processing pathways, particularly homologous recombination (RAD51) and polymerase functions (POL3) .

These effects highlight FEN1's essential role in maintaining genomic integrity during replication. The spectrum of consequences depends on cell type, cell cycle stage, and which alternative pathways remain functional to compensate for FEN1 deficiency.

How does FEN1 contribute to base excision repair?

FEN1 plays a crucial role in long-patch base excision repair (LP-BER), which removes damaged bases that cannot be processed by the short-patch pathway:

  • A DNA glycosylase removes the damaged base, creating an abasic site.

  • AP endonuclease (APE1) cleaves the phosphodiester backbone 5' to the abasic site.

  • DNA polymerase β/δ/ε adds 2-10 nucleotides, displacing the damaged strand and creating a 5'-flap structure.

  • FEN1 recognizes and cleaves this 5'-flap, removing the damaged portion.

  • DNA ligase seals the resulting nick.

The importance of FEN1 in LP-BER is particularly evident when processing oxidized or reduced abasic sites that cannot be removed by the dRP lyase activity of DNA polymerase β. FEN1's precision in this context is critical—inaccurate processing could lead to mutations or persistent DNA damage.

What is the relationship between FEN1 and double-strand break repair?

FEN1 has several connections to double-strand break (DSB) repair pathways:

  • Generation of DSBs: FEN1's gap endonuclease activity can generate DSBs at certain DNA structures, which may initiate homologous recombination at stalled replication forks .

  • Processing of recombination intermediates: FEN1 may process flap structures that arise during synthesis-dependent strand annealing or other recombination-associated DNA synthesis.

  • Synthetic lethal interactions: Studies in yeast show that combining RAD27 (FEN1) deletion with RAD51 (homologous recombination) deficiency results in synthetic lethality, indicating functional relationships between these pathways .

  • Viral manipulation: During HCMV infection, IE1 protein enhances FEN1's DSB-generating activity, suggesting this function can be selectively activated to facilitate viral DNA replication .

These relationships highlight FEN1's versatility beyond its canonical role in Okazaki fragment processing and suggest it functions as an integral component of the cellular response to replication stress.

How is FEN1 regulated in response to DNA damage?

FEN1 activity is dynamically regulated in response to DNA damage through multiple mechanisms:

During HCMV infection, for example, the viral IE1 protein manipulates FEN1 in a novel manner—direct binding enhances both FEN1 stability and phosphorylation at serine 187, correlating with nucleolar exclusion and stimulated gap endonuclease activity . This regulatory flexibility allows FEN1 to respond appropriately to different types of DNA damage and replication stress.

How do single-molecule techniques advance our understanding of FEN1 mechanism?

Single-molecule techniques provide unique insights into FEN1 function not accessible through ensemble measurements:

  • Direct observation of conformational dynamics: Single-molecule studies can capture transient states and conformational changes during FEN1-substrate interactions that would be averaged out in bulk experiments .

  • Kinetic resolution of individual steps: The binding, bending, threading, and catalysis steps can be temporally resolved, revealing rate-limiting steps and potential regulatory points.

  • Detection of heterogeneity: Identification of distinct subpopulations of FEN1-substrate complexes that may follow different reaction pathways.

  • In vivo dynamics: Single-molecule microscopy in living cells can track FEN1 recruitment to replication forks and repair sites with high spatial and temporal resolution .

Recent advances showcased at the "DNA and Interacting Proteins as Single Molecules" conference demonstrate the power of these approaches for studying FEN1 and related nucleases . These techniques are particularly valuable for resolving the threading versus tracking debate and understanding how FEN1 achieves its remarkable substrate specificity.

How do structural studies inform the relationship between FEN1 and other 5' nuclease superfamily members?

Structural studies reveal the evolutionary and functional relationships between FEN1 and other 5' nuclease superfamily members:

Despite recognizing structurally diverse substrates (flaps, bubbles, ends, or Holliday junctions), these enzymes share a conserved catalytic mechanism . The collective structural data suggest that differences in the positioning and flexibility of key structural elements—particularly the helical arch and DNA binding regions—dictate the remarkable substrate specificity of each superfamily member.

Understanding these relationships provides insights into how a conserved catalytic mechanism has been adapted through evolution to process distinct DNA structures arising in different DNA metabolic pathways.

What are the emerging roles of FEN1 in chromatin contexts?

Recent research is uncovering FEN1's functions within chromatin contexts:

  • Chromatin remodeling during DNA replication: FEN1 must function within the constraints of chromatin structure at replication forks, potentially requiring coordination with histone chaperones and chromatin remodelers.

  • Epigenetic maintenance: FEN1's precise processing of Okazaki fragments may influence the inheritance of epigenetic marks during replication.

  • Difficult-to-replicate regions: FEN1 appears to have specialized functions at repetitive sequences, G-quadruplexes, and other non-B DNA structures that form challenging substrates during replication.

  • Single-cell multi-omics approaches: New techniques presented at recent conferences enable researchers to integrate FEN1 function with chromatin state at single-cell resolution .

These emerging areas represent frontiers in FEN1 research, connecting its biochemical activities to higher-order chromatin organization and epigenetic regulation. Studies using single-cell multi-omics sequencing approaches, as presented by researchers like Fuchou Tang, are particularly promising for elucidating these connections .

How does FEN1 contribute to genome instability in cancer?

FEN1's critical roles in DNA metabolism make it a significant factor in cancer development and progression:

  • Expression changes: FEN1 is frequently overexpressed in multiple cancer types, potentially contributing to increased proliferative capacity.

  • Functional mutations: Mutations affecting FEN1 nuclease activity or protein interactions can contribute to genomic instability, a hallmark of cancer.

  • Processing of difficult sequences: Impaired FEN1 function particularly affects repetitive sequences, contributing to the microsatellite instability observed in some cancers.

  • Double-edged role: While FEN1 normally maintains genomic stability, its overexpression may help cancer cells tolerate replication stress, contributing to tumor progression and potentially therapy resistance.

  • Therapeutic implications: The dependency of cancer cells on FEN1 may create opportunities for targeted interventions, particularly in combination with other DNA-damaging agents.

Understanding these complex relationships may guide the development of cancer biomarkers or novel therapeutic approaches targeting FEN1 or its regulatory pathways.

Product Science Overview

Introduction

Flap Structure-Specific Endonuclease 1 (FEN1) is a crucial enzyme in DNA replication and repair processes. It is a member of the XPG/RAD2 endonuclease family and is essential for maintaining genomic stability. FEN1 is known for its ability to remove 5’ overhanging flaps in DNA, which are short sections of single-stranded DNA that “hang off” due to their nucleotide bases being prevented from binding to their complementary base pair . This enzyme plays a significant role in processing the 5’ ends of Okazaki fragments during lagging strand DNA synthesis .

Function and Mechanism

FEN1’s primary function is to ensure the accurate and efficient replication of DNA. During DNA replication, the lagging strand is synthesized in short fragments known as Okazaki fragments. These fragments have 5’ overhanging flaps that need to be removed for the fragments to be joined together seamlessly. FEN1 recognizes and cleaves these flaps, allowing the DNA fragments to be properly ligated .

In addition to its role in DNA replication, FEN1 is also involved in DNA repair processes. It participates in long-patch base excision repair, where it interacts with AP endonuclease 1 to coordinate the loading of proteins onto the DNA substrate . This interaction ensures the efficient repair of damaged DNA and maintains genomic integrity.

Overexpression and Cancer

FEN1 is overexpressed in various types of cancers, including breast, prostate, stomach, neuroblastomas, pancreatic, and lung cancers . Overexpression of FEN1 can lead to the activation of the microhomology-mediated end joining (MMEJ) pathway, an inaccurate DNA repair pathway that often results in mutations. This mutagenic pathway can contribute to the development and progression of cancer .

Recombinant Human FEN1

Recombinant human FEN1 is a laboratory-produced version of the enzyme, used for research and therapeutic purposes. It is produced using recombinant DNA technology, which involves inserting the FEN1 gene into a suitable expression system, such as bacteria or yeast, to produce the enzyme in large quantities. This recombinant enzyme is used in various studies to understand its function, mechanism, and potential therapeutic applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.